1. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M van den Bergh, MD and on behalf of the MASH-2 study group The Lancet Volume 380, Issue 9836, Pages 44-49Volume 380, Issue 9836, Pages 44-49 (July 2012) DOI: 10.1016/S0140-6736(12)60724-7 Copyright © 2012 Elsevier Ltd Terms and ConditionsTerms and Conditions

2. Figure 1 Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)The Lancet 2012; 380:44-49 Terms and Conditions

3. Figure 2 Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)The Lancet 2012; 380:44-49 Terms and Conditions

4. Figure 3 Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)The Lancet 2012; 380:44-49 Terms and Conditions

5. Figure 4 Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)The Lancet 2012; 380:44-49 Terms and Conditions